Is the underutilization of peritoneal dialysis in relation to hemodialysis, as renal replacement therapy, justifiable worldwide? Yes or No

被引:0
作者
Grapsa, E. [1 ]
机构
[1] Alexandra Hosp, Renal Unit, Athens, Greece
关键词
end stage renal disease; peritoneal dialysis; home dialysis; ESRD PATIENTS; CAPD; MULTICENTER; CANUSA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal dialysis is the most important home dialysis treatment for end stage renal diseases and needs personal involvement, and support from the family. Peritoneal dialysis presented a number of discouraging technical problems and led to the belief that PD was not an appropriate renal replacement therapy, for patients with end stage renal disease. Despite the improvement of the method its rate remain low (11%) worldwide. The factors affecting the choice of PD are multiple and explain the disparity in the use of peritoneal dialysis in different countries and different parts of the same country. Dialysis costs and reimbursement structures are significant in decisions about the rates and modalities of renal replacement therapy. Late referral and the health care system seems to be very important factors that influence the dialysis modality choice. After the initiation of peritoneal dialysis we can see other factors that influence the survival of the method. The rate of peritonitis and the peritoneum function seems to be important issues. Hippokratia 2011; 15 (Suppl 1): 13-15
引用
收藏
页码:13 / 15
页数:3
相关论文
共 50 条
  • [21] Comparison of the effect of hemodialysis and peritoneal dialysis in the treatment of end-stage renal disease
    Zhao, Yuan
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1562 - 1567
  • [22] The relation between brain MRI findings and blood manganese levels in renal transplantation, hemodialysis, and peritoneal dialysis patients
    Esra Akcan
    Sultan Özkurt
    Garip Sahin
    Ahmet Ugur Yalcin
    Baki Adapinar
    International Urology and Nephrology, 2018, 50 : 173 - 177
  • [23] The relation between brain MRI findings and blood manganese levels in renal transplantation, hemodialysis, and peritoneal dialysis patients
    Akcan, Esra
    Ozkurt, Sultan
    Sahin, Garip
    Yalcin, Ahmet Ugur
    Adapinar, Baki
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (01) : 173 - 177
  • [24] Health-related quality of life on combination therapy with peritoneal dialysis and hemodialysis in comparison with hemodialysis and peritoneal dialysis: A cross-sectional study
    Tanaka, Mototsugu
    Ishibashi, Yoshitaka
    Hamasaki, Yoshifumi
    Kamijo, Yuka
    Idei, Mayumi
    Kawahara, Takuya
    Nishi, Takahiro
    Takeda, Michio
    Nonaka, Hiroshi
    Nangaku, Masaomi
    Mise, Naobumi
    PERITONEAL DIALYSIS INTERNATIONAL, 2020, 40 (05): : 462 - 469
  • [25] Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure
    Sens, Florence
    Schott-Pethelaz, Anne-Marie
    Labeeuw, Michel
    Colin, Cyrille
    Villar, Emmanuel
    KIDNEY INTERNATIONAL, 2011, 80 (09) : 970 - 977
  • [26] Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease
    Ahmad, Mufazzal
    Robert, Richardson
    Bargman, Joanne M.
    Oreopoulos, Dimitrios
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (04) : 1083 - 1087
  • [27] Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease
    Mufazzal Ahmad
    Richardson Robert
    Joanne M. Bargman
    Dimitrios Oreopoulos
    International Urology and Nephrology, 2008, 40 : 1083 - 1087
  • [28] Temperament and Character Profiles of End Stage Renal Disease Patients Undergoing Hemodialysis and Peritoneal Dialysis
    Orhan, Fatma Ozlem
    Ozer, Ali
    Sayarlioglu, Hayriye
    Dogan, Ekrem
    Altunoren, Ozlem
    Akman, Oguz
    Karaaslan, Mehmet Fatih
    Temizkan, Aysegul
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (03): : 201 - 209
  • [29] Effects of Combination Therapy with Peritoneal Dialysis and Hemodialysis on Left Ventricular Hypertrophy
    Tanaka, M.
    Mise, N.
    Nakajima, H.
    Uchida, L.
    Ishimoto, Y.
    Kotera, N.
    Tanaka, S.
    Kurita, N.
    Sugimoto, T.
    PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (05): : 598 - 600
  • [30] Rational pharmacotherapy and experimental strategies in the treatment of acute renal failure -: Part II -: Extracorporal renal replacement therapy and peritoneal dialysis
    Gabriel, A
    Müller, E
    Tarnow, J
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2001, 36 (04): : 195 - 204